Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies for people with advanced liver disease. Founded by world-renowned experts in liver disease and regenerative medicine, Ambys is pioneering the application of novel modalities including cell and gene therapy, and gain-of-function drug therapy, to meet the urgent need for treatments that have the potential to restore liver function and prevent the progression to liver failure across multiple liver diseases that are untreatable or poorly treated today.

Biotechnology

Education

Ambys Medicines

Ambys Medicines' headquarters in South San Francisco, CA, United States

John Choi

John McKeon

Priyadarshini Podishetti

Stanley Hollenbach

Abeba Demelash Ph.D.

Gabriel Peixoto

Gaetano ‘Nino’ Faleo

Padma Priya Togarrati, Ph.D., RAPS

Marianne Rayos

Juan Carlos Izpisua Belmonte

Holger Willenbring

Martin Burke

Charles Homcy

Chinweike Ukomadu

Robert Fisher

Asit Parikh

Yury Popov

Raymond Chung

Scott Naugler

Brendan Lee

Steven D. Colquhoun

Daniel P. Anderson

Nenad Grmusa

David Russell

Paul Kwo

Stephen Strom

Robert S. Brown Jr.

Jeff Tong

Description

People (5)

Marianne Rayos

Priyadarshini Podishetti

Abeba Demelash Ph.D.

Gabriel Peixoto

Padma Priya Togarrati, Ph.D., RAPS

Jobs